Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$500K Sell
13,166
-11,272
-46% -$401K ﹤0.01% 2682
2026
Q1
$732K Buy
+24,438
New +$776K ﹤0.01% 2252
2022
Q3
Sell
-21,630
Closed -$364K 3156
2022
Q2
$364K Buy
+21,630
New +$393K ﹤0.01% 1886
2022
Q1
Sell
-14,645
Closed -$298K 3454
2021
Q4
$298K Buy
+14,645
New +$292K ﹤0.01% 2280
2019
Q2
Sell
-15,210
Closed -$218K 832
2019
Q1
$218K Buy
+15,210
New +$224K 0.03% 367

Other funds holding IX

HRT Financial's IX Position: Q2 2026 in Review

HRT Financial reduced its ORIX (IX) stake by 46% in Q2 2026, selling an estimated $401K and leaving 13,166 shares worth $500K. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

HRT Financial first reported a position in IX in Q1 2019 and has held it in 5 quarters since. The position peaked at $732K in Q1 2026. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • HRT Financial held 13,166 shares of ORIX worth $500K as of Q2 2026.
  • HRT Financial sold 11,272 ORIX shares in Q2 2026, an estimated $401K.
  • ORIX made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2682 holding.
  • HRT Financial first reported a position in ORIX in Q1 2019 and has held it in 5 quarters since.
  • HRT Financial's ORIX position peaked at $732K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.